Vitamin-Based treatment tested for rare brain disorder
NCT ID NCT04182763
Summary
This study tested whether a vitamin metabolite could help control Pantothenate Kinase-Associated Neurodegeneration (PKAN), a rare genetic brain disorder. Researchers enrolled 77 people with PKAN across North America to check if the treatment was safe and if it affected disease markers. The main goals were to monitor side effects and see if participants could tolerate and stick with the treatment regimen.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.